Eric Walker placed Pembrolizumab under Cancer medications

Eric Walker placed Pembrolizumab under Antibodies

Eric Walker added Scientists See Signs of Lasting Immunity to Covid-19, Even After Mild Infections - The New York Times to a number of topics

Eric Walker added The Male Anglerfish’s Evolutionary Solution to Female Rejection - The New York Times to a number of topics

Eric Walker added a number of topics and a number of links to Immune system, and added Immune system to Physiology

Eric Walker added Monoclonal antibodies and Covid-19 antibodies and immunity to Covid-19 and The Male Anglerfish’s Evolutionary Solution to Female Rejection - The New York Times and Scientists See Signs of Lasting Immunity to Covid-19, Even After Mild Infections - The New York Times to Antibodies, and added Antibodies to Immune system

Eric Walker added a number of topics and Covid-19 patients with cancer, HIV, may play a role in incubating variants - The Washington Post and "Reelin" in a new treatment for multiple sclerosis: Newsroom - UT Southwestern, Dallas, Texas to Monoclonal antibodies, and added Monoclonal antibodies to Antibodies

Eric Walker added Covid-19 and herd immunity and Covid-19 antibody treatments and a number of links to Covid-19 antibodies and immunity to Covid-19, and added Covid-19 antibodies and immunity to Covid-19 to Covid-19 and the immune system and Antibodies